Penicillin-binding proteins involved in high-level piperacillin resistance in Veillonella spp

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 1, 2003, Pages 120-122

  Theron, Maria M ^a   Janse van Rensburg, Marais N ^a   Chalkley, Lynda J ^b  

^a UNIVERSITY OF THE FREE STATE   (South Africa)

^b NONE

Author keywords

Anaerobic bacteria; Gram negative bacteria; Penicillins; Resistance; lactams

Indexed keywords

AMPICILLIN; BETA LACTAMASE; CEFOXITIN; PENICILLIN BINDING PROTEIN; PIPERACILLIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM MUTANT; BINDING AFFINITY; CELL LYSATE; CONTROLLED STUDY; INCUBATION TIME; ISOTOPE LABELING; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR WEIGHT; NONHUMAN; VEILLONELLA;

EID: 0037925141     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg297     Document Type: Article

References (12)

1. Howard, B. J. & Keiser, J. F. (1994). Anaerobic bacteria. In Clinical and Pathogenic Microbiology, 2nd edn (Howard, B. J., Ed.), pp. 383-423. Mosby, St Louis, MO, USA.
2. Bhatti, M. A. & Frank, M. O. (2000). Veillonella parvula meningitis: case report and review of Veillonella infections. Clinical Infectious Diseases 31, 839-40.
3. Marchandin, H., Jean-Pierre, H., Carrière, C. et al. (2001). Note: Prosthetic joint infection due toe Veillonella dispar. European Journal of Clinical Microbiology and Infectious Diseases 20, 340-2.
4. Bryan, L. E. & Godfrey, A. J. (1991). β-Lactam antibiotics: mode of action and bacterial resistance. In Antibiotics in Laboratory Medicine, 3rd edn (Lorian, V., Ed.), pp. 599-664. Williams & Wilkins, Baltimore, Canada.
5. Johnson, C. (1993). Susceptibility of anaerobic bacteria to β-lactam antibiotics in the United States. Clinical Infectious Diseases 16, Suppl. 4, S371-6.
6. Jacobus, N. V., Immerman, F. W., Gupte, J. M. et al. (1993). Susceptibility of anaerobes in phase 3 clinical studies of piperacillin/tazobactam. Clinical Infectious Diseases 16, Suppl. 4, S344-8.
7. Livermore, D. M. (1995). β-Lactamases in laboratory and clinical resistance. Clinical Microbiology Reviews 8, 557-84.
8. Mendes, E., Gordon, S. & Mitchell, D. (1997). Antimicrobial susceptibility of anaerobic bacteria in New South Wales, Australia. In Programs and Abstracts of the Twentieth International Congress of Chemotherapy, Sydney, Australia, 1997. Abstract 4351.
9. Lubbe, M. M., Botha, P. L. & Chalkley, L. J. (1999). Comparative activity of eighteen antimicrobial agents against anaerobic bacteria isolated in South Africa. European Journal of Clinical Microbiology and Infectious Diseases 18, 46-54.
10. Rasmussen, B. A., Bush, K. & Tally, F. P. (1997). Antimicrobial resistance in anaerobes. Clinical Infectious Diseases 24, Suppl. 1, S110-20.
11. National Committee for Clinical Laboratory Methods. (1993). Methods for Antimicrobial Testing of Anaerobic Bacteria. Approved Standard M11-A3. NCCLS, Vlllanova, PA, USA.
12. Wren, M. W. D. (1996). Anaerobic cocci of clinical importance. British Journal of Biomedical Science 53, 294-301.